| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/16/2007 | US20070190112 Treating neovascularization by placing bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer (glycolic acid-lactic acid copolymer); sustained release |
| 08/16/2007 | US20070190106 Phosphorus-containing compounds & uses thereof |
| 08/16/2007 | US20070190077 Anti-HIV agents |
| 08/16/2007 | US20070190064 Enteral composition for the prevention and/or treatment of sepis |
| 08/16/2007 | US20070190054 Prevention and treatment of complement-associated disorders |
| 08/16/2007 | US20070190053 Treament of lupus nephritis with anti-CD40L compounds |
| 08/16/2007 | US20070190043 decreasing or inhabiting hyperproliferation of keratinocytes and/or T-cells ; cream; use treating psoriasis or atopic dermatitis for example |
| 08/16/2007 | DE202006015207U1 Verwendung vn Plasminogenaktivatoren zur Behandlung einer Venenthromboembolie Use vn plasminogen activators for the treatment of venous thromboembolism |
| 08/16/2007 | CA2642665A1 Anti-cancer pharmaceutical composition |
| 08/16/2007 | CA2641859A1 Combinations comprising hcv protease inhibitor(s) and hcv polymerase inhibitor(s), and methods of treatment related thereto |
| 08/16/2007 | CA2641546A1 Therapeutic agent for inflammatory bowel disease containing as active ingredient 2-amino-1,3-propanediol derivative, or method for treating inflammatory bowel disease |
| 08/16/2007 | CA2635797A1 Stable formulations, and methods of their preparation and use |
| 08/15/2007 | EP1818393A1 Neutral sphingomyelinase-3 and its use |
| 08/15/2007 | EP1818325A2 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 08/15/2007 | EP1818063A1 Medicine for treatment of disease caused by hyperstimulatory cytotoxicity and therapeutic method |
| 08/15/2007 | EP1818062A1 An anti HSP90 antibody |
| 08/15/2007 | EP1818056A1 Pharmaceutical combination for the prophylaxis or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases |
| 08/15/2007 | EP1818053A1 Preventive/remedy for allergic diseases |
| 08/15/2007 | EP1818008A1 Noninvasive measurements of chemical substances |
| 08/15/2007 | EP1817057A1 Ptpase inhibitors and t-cell activators for treating cancer |
| 08/15/2007 | EP1817039A2 Treatment and prevention of epilepsy |
| 08/15/2007 | EP1817038A2 Combination comprising zd6474 and an antiandrogen |
| 08/15/2007 | EP1817011A2 Methods and compositions for deterring abuse of orally administered pharmaceutical products |
| 08/15/2007 | EP1816915A1 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 08/15/2007 | EP1816912A2 Treatment of stroke with histamine h3 inverse agonists or histamine h3 antagonists |
| 08/15/2007 | EP1718641B1 Benzimidazole derivative and its use as a ii receptor antagonist |
| 08/15/2007 | EP1673092B1 Heterocycle-substituted pteridine derivatives and their use in therapy |
| 08/15/2007 | EP1663244B1 Pteridine derivatives for the treatment of tnf-alpha-related diseases. |
| 08/15/2007 | EP1613327B1 Pharmaceutical combination containing tamsulosin and a non-steroidal anti-inflammatory drug |
| 08/15/2007 | EP1445327B1 Method of screening drug acting on cell wall |
| 08/15/2007 | EP1435947B1 2-phenyl benzimidazoles and imidazo-¬4,5|-pyridines as cds1/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer |
| 08/15/2007 | EP1368028B1 Benzimidazole compounds for modulating ige and inhibiting cellular proliferation |
| 08/15/2007 | EP1363668B1 Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 08/15/2007 | EP1355588B1 Device for delivery of therepeutic agents |
| 08/15/2007 | EP1353669B1 Method for treating glaucoma |
| 08/15/2007 | EP1343488B1 Treatment of statin side effects |
| 08/15/2007 | EP1339458B1 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity |
| 08/15/2007 | EP1328288B1 Protein mixtures for wound healing |
| 08/15/2007 | EP1292568B1 Benzamide ligands for the thyroid receptor |
| 08/15/2007 | EP1272614B1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 08/15/2007 | EP1259242B1 Use of pdgf receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy |
| 08/15/2007 | EP1254251B1 Neurosteroids as markers for alzheimer's disease |
| 08/15/2007 | EP1250137B1 Jak/stat pathway inhibitors and the use thereof for the treatment of primary generalized osteoarthritis |
| 08/15/2007 | EP1238070B1 Therapeutically useful synthetic oligonucleotides |
| 08/15/2007 | EP1187628B1 Metabolic intervention with glp-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain |
| 08/15/2007 | EP1108023B1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
| 08/15/2007 | EP1073432B1 Use of d-serine or d-alanine for treating schizophrenia |
| 08/15/2007 | EP0869975B1 Assay for and uses of peptide hormone receptor ligands |
| 08/15/2007 | EP0868176B1 Aminoguanidine for treating niddm |
| 08/15/2007 | CN1331853C Small molecule inhibitors of rotamase enzyme activity |
| 08/15/2007 | CN1331533C Medicinal compositions for treating cardiac diseases caused by cardiac hypertrophy |
| 08/15/2007 | CN1331532C Botulinum toxin pharmaceutical compositions |
| 08/15/2007 | CN1331477C Medical nano-carbon tube composition, preparation method and its application |
| 08/15/2007 | CN1331463C Method for chemo-prevention of prostate cancer |
| 08/15/2007 | CN101018799A Composition and method for inhibiting platelet aggregation |
| 08/15/2007 | CN101018567A Induction of apoptosis in Toll-like receptor expressing tumor cells |
| 08/15/2007 | CN101018566A Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 08/15/2007 | CN101018546A (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 08/15/2007 | CN101015695A Retroviral protease inhibitor combination |
| 08/15/2007 | CN101015694A Compound oral preparation for treating spirobacillus infection of pylorus |
| 08/15/2007 | CN101015693A Use of CD25 binding molecules in steroid-resistant patients. |
| 08/15/2007 | CN101015521A Anticancer composition loading both antimetabolite medicament and synergistic agent |
| 08/14/2007 | US7256307 Substituted phenypropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor α(PPAR) |
| 08/14/2007 | US7256263 High molecular weight Dermatophagoides proteins, and nucleic acids encoding them; used to treat and diagnose mite allergies |
| 08/14/2007 | US7256219 Multifluoro-substituted chalcones and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/14/2007 | US7256205 2-Aminothiazole histamine H2 receptor antagonists such as famotidine or nizatidine to which is linked at least one NO and/or NO2 group; treating inflammations including gastrointestinal disorders and reducing the gastrointestinal toxicity associated with the use of NSAIDS |
| 08/14/2007 | US7256200 administering mixture of opioid and calmodulin kinase inhbitor |
| 08/14/2007 | US7256193 Therapeutic agents useful for treating pain |
| 08/14/2007 | US7256183 Administering a nucleotide receptor agonist (such as adenosine triphophate or uridine triphosphate); sinusitis, rhinitis, conjunctivitis, asthma, dermatitis, inflammatory collagen vascular diseases, glomerulonephritis; antiallergens |
| 08/14/2007 | US7256028 Methods for screening compounds that modulate lipid metabolism |
| 08/14/2007 | US7255984 Combination therapy for osteoporosis |
| 08/14/2007 | US7255882 Enkephalinase inhibitor and GABA precursor loading as anti-anxiety compositions |
| 08/14/2007 | US7255868 Hybrid immunomodulatory peptide and nucleotide sequences for treating allergies |
| 08/14/2007 | US7255867 Group A streptococcal antigen combined with proteosome adjuvant; prevention or reduction of throat colonization; intranasal administration |
| 08/14/2007 | US7255854 Use of lymphotoxin-β receptor blocking agents for the treatment of antibody mediated immunological diseases |
| 08/14/2007 | US7255850 The rates of the two arms of reverse cholesterol transport (HDL or first arm and post-HDL or second arm) are obtained by measuring the flow of unlabeled cholesterol from tissues into plasma HDL and from plasma HDL to bile acids |
| 08/14/2007 | CA2390189C Methods and pharmaceutical compositions for preventing problem behaviors of companion animals |
| 08/14/2007 | CA2370030C Sodium channel blocker compositions and the use thereof |
| 08/14/2007 | CA2239624C Treatment of negative and cognitive symptoms of schizophrenia with glycine uptake antagonists |
| 08/14/2007 | CA2239421C Composition and method for reducing recovery time in anaesthetised mammals |
| 08/09/2007 | WO2007089787A2 Compositions and methods for treating cardiovascular, cerebrovascular and other vascular disease patients |
| 08/09/2007 | WO2007089166A1 Medicinal preparation for jugulating a systemic inflammatory response syndrome |
| 08/09/2007 | WO2007089043A1 Liposome preparation |
| 08/09/2007 | WO2007088952A1 Liposome preparation comprising substance having anti-tumor activity |
| 08/09/2007 | WO2007088712A1 Neuronal cell death inhibitor and screening method |
| 08/09/2007 | WO2007088651A1 JOINT USE OF TGF-β SIGNAL INHIBITOR AND ANTITUMOR AGENT |
| 08/09/2007 | WO2007088476A1 Methods for treating unwanted weight loss or eating disorders by administering a trkb agonist |
| 08/09/2007 | WO2007088399A1 Upregulation of adamts4 protease activity for the treatment of alzheimer's disease |
| 08/09/2007 | WO2007088343A2 Granular material comprising water- insoluble inorganic phosphate binders |
| 08/09/2007 | WO2007088050A2 Method of treatment for muscular dystrophy |
| 08/09/2007 | WO2007087667A2 Combination preparation for improving sperm quality |
| 08/09/2007 | WO2007054725A3 Combination of a cdk-inhibitor and a hdac-inhibitor |
| 08/09/2007 | WO2007053194A3 Modulation of cell barrier dysfunction |
| 08/09/2007 | WO2007047978A3 Modulation of neurogenesis by pde inhibition |
| 08/09/2007 | WO2007041637A3 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| 08/09/2007 | WO2007039760A3 Use of oligouronates for treating mucus hyperviscosity |
| 08/09/2007 | US20070185213 Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines |
| 08/09/2007 | US20070185068 Use of sex steroid function modulators to treat wounds and fibrotic disorders |
| 08/09/2007 | US20070185048 ATP-binding cassette transporter polypeptide which regulates metabolism of triglycerides; treatment of obesity and eating disorders |
| 08/09/2007 | US20070185022 Therapeutic composiitons comprising bactericidal/permeability-increasing (BPI) protein products |